BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28337208)

  • 1. Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin
    Bozzano F; Marras F; De Maria A
    Front Immunol; 2017; 8():268. PubMed ID: 28337208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34
    Perrone C; Bozzano F; Dal Bello MG; Del Zotto G; Antonini F; Munari E; Maggi E; Moretta F; Farshchi AH; Pariscenti G; Tagliamento M; Genova C; Moretta L; De Maria A
    Front Immunol; 2024; 15():1332781. PubMed ID: 38390333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCMV-controlling NKG2C
    Bozzano F; Della Chiesa M; Pelosi A; Antonini F; Ascierto ML; Del Zotto G; Moretta F; Muccio L; Luganini A; Gribaudo G; Cenderello G; Dentone C; Nicolini L; Moretta A; Moretta L; De Maria A
    J Allergy Clin Immunol; 2021 Jun; 147(6):2343-2357. PubMed ID: 33493558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK Cell Precursors in Human Bone Marrow in Health and Inflammation.
    Bozzano F; Perrone C; Moretta L; De Maria A
    Front Immunol; 2019; 10():2045. PubMed ID: 31555276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation.
    Bozzano F; Marras F; Ascierto ML; Cantoni C; Cenderello G; Dentone C; Di Biagio A; Orofino G; Mantia E; Boni S; De Leo P; Picciotto A; Braido F; Antonini F; Wang E; Marincola F; Moretta L; De Maria A
    Nat Commun; 2015 Oct; 6():8109. PubMed ID: 26436997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment.
    Taramasso L; Bozzano F; Casabianca A; Orlandi C; Bovis F; Mora S; Giacomini M; Moretta L; Magnani M; Di Biagio A; De Maria A
    Front Immunol; 2022; 13():847816. PubMed ID: 35558085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human thymic stroma supports human natural killer (NK) cell development from immature progenitors.
    Vaz F; Srour EF; Almeida-Porada G; Ascensao JL
    Cell Immunol; 1998 Jun; 186(2):133-9. PubMed ID: 9665755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel population of natural killer progenitor cells isolated from human umbilical cord blood.
    Cicuttini FM; Martin M; Petrie HT; Boyd AW
    J Immunol; 1993 Jul; 151(1):29-37. PubMed ID: 7686936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of dendritic cells from lymphoid precursors.
    Galy A
    Methods Mol Med; 2001; 64():275-81. PubMed ID: 21374267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNAM-1 expression marks an alternative program of NK cell maturation.
    Martinet L; Ferrari De Andrade L; Guillerey C; Lee JS; Liu J; Souza-Fonseca-Guimaraes F; Hutchinson DS; Kolesnik TB; Nicholson SE; Huntington ND; Smyth MJ
    Cell Rep; 2015 Apr; 11(1):85-97. PubMed ID: 25818301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
    Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A
    Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of developmental pathway of natural killer cells from embryonic stem cells in vitro.
    Tabatabaei-Zavareh N; Vlasova A; Greenwood CP; Takei F
    PLoS One; 2007 Feb; 2(2):e232. PubMed ID: 17311098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.
    Xiong P; Sang HW; Zhu M
    Immunology; 2015 Nov; 146(3):369-78. PubMed ID: 26235210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.
    Carlsten M; Baumann BC; Simonsson M; Jädersten M; Forsblom AM; Hammarstedt C; Bryceson YT; Ljunggren HG; Hellström-Lindberg E; Malmberg KJ
    Leukemia; 2010 Sep; 24(9):1607-16. PubMed ID: 20613786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes.
    Clausen J; Enk M; Vergeiner B; Eisendle K; Petzer AL; Gastl G; Gunsilius E
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):691-7. PubMed ID: 15389435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
    Sivori S; Cantoni C; Parolini S; Marcenaro E; Conte R; Moretta L; Moretta A
    Eur J Immunol; 2003 Dec; 33(12):3439-47. PubMed ID: 14635054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD34(+) thymocyte maturation: pre-T and NK cell differentiation on neonatal thymic stromal cell culture.
    Sarun S; Dalloul AH; Laurent C; Blanc C; Schmitt C
    Cell Immunol; 1998 Nov; 190(1):23-32. PubMed ID: 9826443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
    Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
    Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic functions and susceptibility to apoptosis of human CD56(bright) NK cells differentiated in vitro from CD34⁺ hematopoietic progenitors.
    Zamai L; Del Zotto G; Buccella F; Galeotti L; Canonico B; Luchetti F; Papa S
    Cytometry A; 2012 Apr; 81(4):294-302. PubMed ID: 22319021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.